Community Generated Content – SmartSky Networks
Fastest ATG now available for Textron’s best-selling mid-size jet RESEARCH TRIANGLE, N.C. , Feb. 8, 2024 /PRNewswire/ — SmartSky Networks, the leading provider of inflight air-to-ground (ATG) connectivity for business aviation, today announced that sales and installation partner Davinci Jets has completed its third SmartSky STC installation, bringing game changing connectivity to a customer-owned Citation Latitude. The SmartSky…
Latest
Articles
Discovering the SmartSky User Experience
Hear a user experience with the remarkable system with low latency and high bandwidth. They were able to accomplish all their tasks without any issues. People interested in this technology desire the ability to have meetings in the sky, and this system makes that possible.
Articles
The Future of In-Flight Connectivity: SmartSky’s Presence at Gulfstream Suppliers and Operators Conference 2022
Check out SmartSky at the Gulfstream Suppliers and Operators Conference.
Articles
SmartSky Takes Flight at NBAA Maintenance Conference 2022
The NBAA maintenance conference in San Antonio, Texas, commenced with SmartSky Networks taking center stage. With an impressive display of their live network, they showcased a remarkable product that is readily available for installation. The long-awaited solution for reliable internet connectivity has finally arrived, putting an end to the uncertainties faced by aviation enthusiasts. SmartSky…
Articles
SmartSky Networks and GAT
Passengers recently had an unforgettable experience thanks to GAT and SmartSky Networks. The event showcased SmartSky’s groundbreaking in-flight internet connectivity network, leaving attendees amazed at its capabilities and potential impact on the aviation industry. Participants boarded an aircraft equipped with SmartSky’s advanced connectivity solution and witnessed the seamless and lightning-fast internet connectivity firsthand. Even at…
Articles
Announcing the Winner of SmartSky Fast Track Sweepstakes
A quick sound bite announcing the Winner of SmartSky Fast Track Sweepstakes.
Articles
Building Success through Collaboration: Appreciating Our Valued Partners
An overview of partners of SmartSky Networks. See all of the partners working with SmartSky networks.
Latest
Analyzing the Suppressive TME in In Vitro Based Assays
In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…
Targeting T Cells Within the Cancer Immunity Cycle
As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…
Inside Oncology Drug Development: Overcoming Resistance with Science
In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…
